BCB
GSK icon

Brian C. Broderick’s GSK GSK Stock Holding History

Brian C. Broderick’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,682
Closed -$518K – 107
2014
Q4 		$518K Sell
9,682
-46,708
-83% -$2.61M 0.22% 70
2014
Q3 		$3.24M Buy
56,390
+140
+0.2% +$8.58K 1.44% 27
2014
Q2 		$3.76M Buy
56,250
+3,120
+6% +$211K 1.72% 25
2014
Q1 		$3.55M Buy
53,130
+2,420
+5% +$164K 1.74% 22
2013
Q4 		$3.38M Buy
50,710
+14,768
+41% +$958K 1.68% 22
2013
Q3 		$2.25M Buy
35,942
+9,920
+38% +$639K 1.26% 29
2013
Q2 		$1.63M Buy
+26,022
New +$1.65M 0.97% 31

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brian C. Broderick's GSK Position: Q1 2015 in Review

Brian C. Broderick sold out of GSK (GSK) in Q1 2015, closing a stake of 9,682 shares — an estimated $518K sold.

Brian C. Broderick first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $3.76M in Q2 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Brian C. Broderick reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • Brian C. Broderick sold 9,682 GSK shares in Q1 2015, an estimated $518K.
  • Brian C. Broderick first reported a position in GSK in Q2 2013 and held it in 7 quarters.
  • Brian C. Broderick's GSK position peaked at $3.76M in Q2 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Brian C. Broderick's 13F filing for Q1 2015, filed 22 May 2015.